iTeos Therapeutics Inc. (NASD: ITOS) will replace Magellan Health Inc. (NASD: MGLN) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, January 5. S&P 500 constituent Centene Corp. (NYSE: CNC) is acquiring Magellan Health in a deal expected to be completed soon pending final conditions.
Following is a summary of the changes that will take place prior to the open of trading on the effective date:
Effective Date | Index Name | Action | Company Name | Ticker | GICS Sector |
January 5, 2022 | S&P SmallCap 600 | Addition | iTeos Therapeutics | ITOS | Health Care |
S&P SmallCap 600 | Deletion | Magellan Health | MGLN | Health Care |
For more information about S&P Dow Jones Indices, please visit www.spdji.com
https://finance.yahoo.com/news/iteos-therapeutics-set-join-p-224400392.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.